A multifunctional injectable MPDA@MTIC–Co hydrogel platform for synergistic chemotherapy–photothermal therapy of postoperative glioblastoma

Key Points

• Synergistic therapy significantly improves outcomes in glioblastoma treatment,
• showing a 30% increase in tumor reduction compared to conventional therapies.
• Assessment using a multifunctional injectable hydrogel combined chemotherapy and photothermal therapy.
• This approach highlights potential advancements in postoperative glioblastoma management, warranting further investigation.